baber/WOPTO huggingface dataset:
Patent JP-H10500226-A (JP)
Title: 低コスト、軽量、コンパクトな双眼鏡
IPC: G02B7/12
Filed: 1995-05-02
Abstract: (57)【要約】
低コスト、軽量、コンパクトな双眼鏡は、伝統的なプリズムに代えて高反射のミラー（１１５）を利用し、像の方向性の補正のため対物レンズ（１２５）とフィールドレンズ（１２１）の間の距離を長くする。双眼鏡はミラーを用いて製作され、インジェクションモールドによるアクリルプラチックレンズにより軽量となる。これらはポケットサイズ化され、コンパクトで、更に個人的な眼間距離が調整可能である。観察視野は長方形の形態で、相互瞳間の調整は重ね合わされるハウジング（５，７）間のスライド動作に手段による。
Patent JP-H10507902-A (JP)
IPC: C12N15/09
Filed: 1995-05-18
Abstract: A method of diagnosing cat scratch disease and a method of diagnosing bacillary angiomatosis in a subject by detecting the presence of Rochalimaea henselae or an antigenic fragment thereof in the subject is provided. Also provided is a vaccine comprising an immunogenic amount of a nonpathogenic Rochalimaea henselae or an immunogenically specific determinant thereof and a pharmaceutically acceptable carrier. A method of diagnosing Rochalimaea quintana infection in a subject by detecting the presence of a nucleic acid specific to Rochalimaea quintana in a sample from the subject is provided. A purified, 60-kDa heat shock protein of Rochalimaea is provided. Also provided is a 17-kDa antigenic polypeptide of Rochalimaea.
Patent JP-2000508225-A (JP)
Title: 使い捨てチュービングセットおよび可撓性チュービング保持用編成フレーム
IPC: A61B5/15
Filed: 1997-12-11
Abstract: (57)【要約】
可撓性チュービングアレイを有する使い捨てチュービングセット（１０）、および可撓性チュービングアレイを保持する方法。この使い捨てチュービングセットは、チュービングのセグメント（３８）を保持するフレーム（３６）を有する。フレーム（３６）は、少なくとも２つの側部と、この側部内に規定された複数の開口部とを有する。チュービングのセグメント（３８）は、開口部を通って延び、且つ開口部によって完全に囲まれる。
Patent JP-2001526580-A (JP)
IPC: B01J13/00
Filed: 1997-02-24
Abstract: A process for the subcritical drying of a lyogel to give an aerogel comprises treating the lyogel with a heat transfer liquid which has a temperature above the boiling point of the pore liquid of the lyogel under the pressure of the system and subsequently separating the dried aerogel from the heat transfer liquid.
Patent JP-2000506311-A (JP)
Title: 傾斜したｐｎ接合を有するバイポーラｓｏｉデバイスおよびそのようなデバイスの製造方法
IPC: H01L29/06
Filed: 1997-03-05
Abstract: (57)【要約】
絶縁体（３）の上の半導体ウエハ、例えば単結晶シリコンウエハ（２）中にエミッタ領域（４）、ベース領域（５）、コレクタ領域（２）、およびコレクタコンタクティング領域（６）を含むバイポーラ型の絶縁体上半導体トランジスタデバイス（１）において、ベース・エミッタおよびコレクタ・ベース接合が半導体ウエハ（２）と絶縁体（３）との間の界面に対して傾斜している。本デバイスは、デバイスの端部に傾斜した表面（７）または等価なように傾斜した表面を有するＶ字形の溝を形成する目的での異方性エッチングによって形成される。ベースおよびエミッタ領域（５、４）が次に、適当なドナーおよびアクセプター原子を傾斜した表面内部の材料中へ拡散させることによって形成される。そのようなバイポーラ型の絶縁体上半導体トランジスタは、横型半導体デバイスの高速特性と縦型半導体デバイスの高電圧特性とを組み合わせている。
Patent JP-H11504072-A (JP)
Title: 強固なバリヤ・コーティングの蒸着のためのマイクロ波ｃｖｄ法
IPC: C23C16/40
Filed: 1996-04-08
Abstract: (57)【要約】
マイクロ波プラズマ強化CVD（Chemical Vapor Deposition: 化学的気相成長法）によって、変成された酸化シリコンのバリヤ・コーティングを温度敏感性基板上に蒸着する方法であり、前記バリヤ・コーティングが、少なくとも気体酸素および水蒸気にたいしてバリヤ特性を持つ方法である。前駆気体混合物は、少なくともシリコン・水素含有気体、酸素含有気体ならびに、ゲルマニウム、すず、燐およびボロンから成るグループから選択された少なくとも1つの元素を含有する気体を含む。本方法は、充分な流量の酸素含有気体を前駆気体混合物中に導入して、シリコン・水素結合の蒸着済みコーティング中への介在を消滅させることを必要とする。好ましい変成材はゲルマニウムである。また、複合材料は、マイクロ波プラズマ強化CVD蒸着された酸化シリコン（変成されたものまたは変成されていないもの）のバリヤ・コーティングを持つ。バリヤ・コーティングは、少なくとも気体酸素および水蒸気にたいしてバリヤ特性を持ち、実質的にSi-H結合を持たない。バリヤ・コーティングは本発明によれば、温度敏感性基板上に蒸着される。
Patent JP-H11505226-A (JP)
Title: 切り花の保存方法、および切り花の保存用組成物
IPC: C05G5/23
Filed: 1996-05-10
Abstract: (57)【要約】
水溶性のポリアミノ有機酸、好ましくはポリアスパラギン酸の溶液に切り花の切断状態の茎を挿入することからなる、バラ、チューリップ、カーネーション、菊などの切り花の保存方法。茎折れやしおれのない状態を未処理切り花に比較して多くの場合２〜３倍長く保持できる。
Patent JP-2002513306-A (JP)
Title: 運動シューズ用ソール
IPC: A63B23/04
Filed: 1998-01-22
Abstract: (57)【要約】
着用者の足が載る上面と下方の接地面（３６，７２）とを有するソール（３２，３５，９２）を含む運動用具。ソールの下面は、着用者の第１及び第２の中足骨−指節骨関節の中点を連結するライン（５６）を中心として円筒状湾曲状態にほぼ丸みがつけられている。
Patent JP-2000507830-A (JP)
Title: 超音波害虫防除器
IPC: A01M29/02
Filed: 1996-04-09
Abstract: (57)【要約】
容器に収納され、電池により動作し、特定の害虫にとって不快な３６キロヘルツから４１キロヘルツの範囲の周波数を発する超音波変換器もしくは超音波発信器を含み、動作シーケンスを制御するマイクロプロセッサまたはタイマスイッチを含んでいる超音波害虫防除器。
Patent JP-H11506027-A (JP)
Title: 靴底用のインサート
IPC: A43B13/12
Filed: 1996-05-07
Abstract: (57)【要約】
靴（１０）の中底本体（１２）用のインサート（４４）は、ヒールストライク時に足からのエネルギーを吸収し、ヒールリフトオフ時にこのエネルギーを足に返すヒールレバー（５２）を含む。
Patent JP-2000509756-A (JP)
Title: 耐久性顔料のための改良された顔料方法
IPC: C09C3/06
Filed: 1998-02-25
Abstract: (57)【要約】
プラスチック又は塗料組成物において良好な耐久性、分散性、及び光学特性を示す、Ａｌ 2 Ｏ 3 、ＳｉＯ 2 、もしくはＰ 2 Ｏ 5 源のような任意の他の酸化物、又はそれらの混合物の第１コーティング、ＺｒＯ 2 、ＳｎＯ 2 、ＴｉＯ 2 、ＳｉＯ 2 、ＣｅＯ 2 又はそれらの混合物の任意コーティング、及びＡｌ 2 Ｏ 3 の最終コーティングを有する改良された被覆無機顔料が開示される。また、無機顔料の水性スラリーを練磨して特定の粒径分布を達成し、Ａｌ 2 Ｏ 3 、ＳｉＯ 2 もしくはＰ 2 Ｏ 5 源のような任意の他の酸化物又はそれらの混合物の第１コーティングを第１のｐＨ範囲内で前記顔料材料上に析出させ、任意の量のＺｒＯ 2 、ＳｎＯ 2 、ＳｉＯ 2 、ＴｉＯ 2 、ＣｅＯ 2 又はそれらの混合物を第２のｐＨ範囲内で前記水性スラリーに添加して前記第１コーティング上に任意コーティングを得、かつＡｌ 2 Ｏ 3 の最終コーティングを先行するコーティング（１つもしくは複数）上に追加する方法も開示される。
Patent JP-2002511832-A (JP)
Title: 液状有機廃棄物を処理するための方法およびプラント
IPC: C05F17/02
Filed: 1998-02-20
Abstract: (57)【要約】
液状の有機廃棄物質、例えば家畜に由来する液状動物ふん尿を処理するための方法およびプラントであって、この液状物から繊維および粒子を濾過すること、液状物をバイオガス・リアクター内で嫌気的発酵に供すること、例えば限外濾過を用いて、実質的に無菌で粒状物を含まない透過物ストリームをバイオガス・リアクターから分離すること、透過物ストリームを高温下および好ましくは減圧下におけるアンモニア・ストリッパーを用いる処理に供して実質的にすべてのアンモニアおよび二酸化炭素を除去し、アンモニア・フラクションと栄養塩フラクションとを得ること、ならびに、例えば逆浸透法を用いて、栄養塩フラクションを肥料濃縮物フラクションと水フラクションとに分離することを含む方法。本発明の方法の最終生産物は、クリーンな水、アンモニア濃縮物、ＰおよびＫの塩を含む肥料濃縮物、コンポスト、および高いメタン含有量を有する高品質のバイオガスである。
Patent JP-2000513333-A (JP)
IPC: A61K38/43
Filed: 1997-05-01
Abstract: The present invention includes a method for producing an implantable polymer/drug matrix mass, comprising the steps of (1) forming a polymer solution/drug mixture comprising a polymer dissolved in an organic solvent and a suspended labile drug; (2) removing the solvent from the polymer solution/drug mixture, thereby forming a solid polymer/drug matrix; and (3) mechanically compressing the polymer/drug matrix, thereby forming an implantable polymer/drug matrix mass.
Patent JP-2000511355-A (JP)
IPC: B24B37/015
Filed: 1997-05-21
Abstract: The present invention is a method for chemical-mechanical planarization of semiconductor wafers that is highly useful for planarizing stop-on-feature design wafers. Initially, the wafer is positioned against a liquid solution over a planarizing surface of a polishing pad. At least one of the wafer or the pad is moved with respect to the other at a relatively low velocity to maintain a substantially continuous film of liquid solution between the wafer and the pad. The temperature of a pad platen is also controlled to maintain a relatively low temperature of the liquid solution at which the solution is highly selective to a layer of material on the wafer.
Patent JP-2001521519-A (JP)
IPC: G03F7/027
Filed: 1998-03-23
Abstract: This invention relates to a novel class of halofluorinated acrylates and more particularly to chlorofluorinated or bromofluorinated acrylates characterized by a chlorofluorinated or bromofluorinated alkylene moiety with acrylate functions at both terminals. These chlorofluorinated acrylates may be photocured in the presence of a photoinitiator into transparent polymers useful as optical waveguiding materials.
Patent JP-2001523281-A (JP)
IPC: C08L23/10
Filed: 1998-04-21
Abstract: Halogen-free thermoplastic blends of a polar rubber, ethylene vinyl acetate and a polyolefin. are provided which are flexible and are particularly useful in replacing polyvinyl chloride for production of various products.
Patent MX-154334-A (MX)
Inventor: CABI-AKMAN ROBERT
IPC: G01N21/55
Filed: 1983-09-27
Abstract: A sample to be measured, a black reference and at least one reference having a color similar to that of the sample are exposed successively and cyclicly to the same incident light beam, the light beams which are reflected successively by the sample and the references are detected photoelectrically, the ratio of the intensities of the light beams reflected by a sample and one reference color on the one hand and by the black reference and a reference color on the other hand is established electronically, the second ratio is subtracted electronically from the first and a difference which is directly proportional to the brilliance of the color of the sample is automatically obtained during each exposure or measurement cycle at a determined measurement frequency (FIG. 1).
Patent NZ-197048-A (NZ)
Title: N-(-mercaptoalkanoyl)heterocycles
Inventor: SUH J T
IPC: C07D217/26
Filed: 1981-05-11
Abstract: Compounds of the formula  <IMAGE>  wherein: R1, R2, R3, R4, R6, and R7 are independently hydrogen or lower alkyl. R5 is hydrogen, lower alkyl, rad alkanoyl having 1 to 6 carbon atoms. Y is OH or OM wherein M is a pharmaceutically acceptable cation, and n is an integer from 0 to 1, and X1 and X2 are independently (CR8R9)m wherein R8 and R9 are independently hydrogen or lower alkyl and m is an integer from 1 to 5 are potent angiotensin converting enzyme inhibitors and possess antihypertensive activity.
Patent NZ-197130-A (NZ)
Title: (alkyl or haloalkyl) 1-(1,2,4-triazol-1-yl) vinyl ketones or carbinols
Inventor: ELKE H
IPC: A01N43/64
Filed: 1981-05-18
Abstract: A triazolyl-vinyl ketone or carbinol of the formula   <IMAGE>   in which A represents the keto group or a CH(OH) grouping, R1 represents alkyl or halogenoalkyl and R2 represents a primary or tertiary alkyl radical, halogenoalkyl, alkoxyalkyl, alkylmercaptoalkyl, dialkylaminoalkyl, hydroxyalkyl, an optionally substituted alkenyl, alkynyl or alkenynyl radical, phenylalkyl which is optionally substituted in the alkyl part and/or in the phenyl part, an optionally substituted indenyl or fluorenyl radical, or an optionally substituted diphenylmethyl or triphenylmethyl radical, or an addition product thereof with a physiologically acceptable acid or a metal salt, which possesses fungicidal activity.
Patent NZ-207999-A (NZ)
Title: Preparing biaxially oriented monolayer polyamide blown film
Inventor: LANCASTER G M
IPC: C08L77/00
Filed: 1984-04-30
Abstract: The preparation of monolayer blown nylon films on equipment conventionally used in the manufacture of blown polyethylene film is facilitated by the intimate admixture of a minor proportion by weight of a random ethylene/ethylenically unsaturated carboxylic acid copolymer into the nylon resin composition from which said blown nylon film is to be manufactured.
Patent NZ-213680-A (NZ)
Title: Monoclonal antibody to cyclosporin and process for its production
Inventor: ROSENTHALER JOACHIM
IPC: C07K16/00
Filed: 1985-10-02
Abstract: Immunogenic conjugates comprising a carrier coupled to a cyclosporin having an activate coupling group, e.g. activated carboxy group, e.g. (i) [(O-succinimidooxysuccinyl)-Thr]<2>-Cyclosporine and (ii) [(N- epsilon -succinimidooxysuccinyl)-(D)Lys]<8>-Cyclosporine. The subject conjugates are useful for the generation of monoclonal antibodies capable of distinguishing between cyclosporins, e.g. Cyclosporine, and metabolites, e.g. Cyclosporins 17 and 18.
Patent NZ-219423-A (NZ)
Title: Genetically modified plants resistant to glutamine synthetase inhibitors
Inventor: GOODMAN H M
IPC: C12N9/06
Filed: 1987-02-26
Abstract: A plant cell which is resistant to a herbicidal glutamine synthetase (GS) inhibitor, wherein the resistance is caused by levels of GS activity which, when present in an otherwise herbicidal GS inhibitor sensitive plant cell, render the cell substantially resistant to the herbicidal GS-inhibitor. The plant cell may, for example, carry a genetic sequence combination comprising a first genetic sequence coding for genomic GS functional in the plant cell operably linked to a second genetic sequence capable of increasing the levels of expression of the first genetic sequence, thereby increasing the levels of GS activity within the cell.
Patent NZ-224252-A (NZ)
Title: An anthracycline glycoside and its preparation
Inventor: CARUSO MICHELE
IPC: C07C225/34
Filed: 1988-04-14
Abstract: Anthracycline glycosides of formula (I) and their pharmaceutically acceptable acid addn. salts are new where R1 = H or OH; one of R2 and R3 = H, the other is H or OH. Also new are the intermediates 4-demethoxy-4-amino -7-deoxy-daunomycinone (IX) and daunomycinones (II), opt. N-protected. - (I) is pref. 4-demethoxy-4 -amino-daunorubicin; 4-demethoxy- 4-amino-4'-epi-daunorubicin or 4-demethoxy-4-amino -4'-deoxy-daunorubicin, and the corresp. doxorubicin cpds.
Patent NZ-225611-A (NZ)
Title: Pharmaceutical composition containing at least one sulphated polysaccharide and at least one xanthine derivative
Inventor: SCHRINNER ELMAR
IPC: C07D473/06
Filed: 1988-07-29
Abstract: The preparation contains or consists of
 a) at least one sulphated polysaccharide and
 b) at least one xanthine derivative. The preparation is suitable for the control and prophylaxis of viral diseases, especially those caused by retroviruses.
Patent NZ-227951-A (NZ)
Title: Closure capsule for container: sliding member in capsule opens container to dispense contents
Inventor: SIMON PATRICK
IPC: B65D47/28
Filed: 1989-02-10
Abstract: Closure capsule (2) with a movable element for vials and other containers which must be opened or closed without withdrawal of the capsule, characterised in that it comprises an envelope (6) connected to the vial (1) by attachment elements (4, 5), the said envelope (6) having a bottom (7) and an opening intended to be brought into coincidence with that (17b) of a drawer (16) mounted in a slide (8) formed below the bottom (7) and having a bottom wall (10) in which an opening (11) is formed connecting with the interior of the vial (1), the said drawer (16) being provided with operating means (18, 23, 24, 32, 38) protruding from the envelope (6) and elements (19, 19a, 33) being provided for holding the capsule (2) closed in the non-operating position. <IMAGE>
Patent NZ-232850-A (NZ)
Title: Absorbent article: elasticised leg cuffs with low contact force
Inventor: FREELAND MARY ELAINE
IPC: A61F13/56
Filed: 1990-03-08
Abstract: A disposable absorbent article such as a diaper (10), is disclosed. The diaper has two lengthwise extending longitudinal marginal portions (50), each longitudinal marginal portion having two elastically extensible leg cuffs, a barrier cuff (62) and a gasket cuff (56). The leg cuffs (56,62) serve to help contain body exudates within the disposable article. Each leg cuff (56,62) is elasticized to provide a relatively low ultimate contact force against the skin of the wearer at relatively high elongations. This arrangement provides a diaper with leg cuffs which can be elongated to conform to the shape of the wearer, without causing undue discomfort or irritation to the legs of the wearer. The relatively low ultimate contact force at relatively high elongations may be accomplished either through a low contact force differential material, or through a material which exhibits stress relaxation over a relatively short period of time.
Patent NZ-238255-A (NZ)
Title: Type ii interleukin i receptor proteins and their preparation
Inventor: SIMS JOHN E
IPC: C07K16/00
Filed: 1991-05-24
Abstract: Type II IL-1 receptor (type II IL-1R) proteins, DNAs and expression vectors encoding type II IL-1R, and processes for producing type II IL-1R as products of recombinant cell culture, are disclosed. <IMAGE>
Patent NZ-278870-A (NZ)
Title: Composition containing sodium bicarbonate and monocarbonate for purifying flue gases from refuse incineration, removal of hydrogen chloride from gases
Inventor: FAGIOLINI NILO
IPC: B01D53/50
Filed: 1995-01-12
Abstract: Solid powdered reactive composition for the purification of a gas containing hydrogen chloride, the said reactive composition comprising more than 98% by weight of sodium bicarbonate and less than 2% by weight of sodium monocarbonate and exhibiting a particle size distribution defined by an average particle diameter of less than 0.050 mm and a particle size slope of less than 5.The reactive composition finds an application in the purification of flue gases from the incineration of household waste.
Patent NZ-286602-A (NZ)
Title: [alpha-(alkylaminomethyl)-3,4-dichlorobenzylthio]acetamide and treatment of dopamine-related disorders
Inventor: LAURENT PHILLIPE
IPC: A61P25/28
Filed: 1996-05-16
Abstract: Use of a cpd. of formula (I) selected from ( alpha -(tert.-butylaminomethyl)- 3,4-dichlorobenzyl)thioacetamide (Ia) and its laevorotatory (i.e. (-)) isomer, ( alpha -(tert.-amylaminomethyl)- 3,4-dichlorobenzyl)thioacetamide (Ib) and its isomers and ( alpha -(1-adamantylaminomethyl)- 3,4-dichlorobenzyl)thioacetamide (Ic) and its isomers, or their acid addn. salts, is claimed for the prepn. of a dopamine re-uptake inhibiting medicament. In the formula, R = tert.-butyl in (Ia), tert. amyl in (Ib) or 1-adamantyl in (Ic). Also claimed are (-)-(Ia) and its acid addn. salts (specifically the hydrochloride); (Ib) and its isomers and acid addn. salts; and (Ic) and its isomers and acid addn. salts are new cpds.
Patent NZ-300982-A (NZ)
Title: Catalyst comprising zinc metal or oxide, a rare earth metal oxide (not rhodium) and at least one of palladium, platinum, nickel, cobalt and iron for use in catalytic exhaust systems
Inventor: THOMSON JAMES
IPC: B01J23/83
Filed: 1996-02-02
Abstract: PCT No. PCT/GB96/00239 Sec. 371 Date Jan. 9, 1998 Sec. 102(e) Date Jan. 9, 1998 PCT Filed Feb. 2, 1996 PCT Pub. No. WO96/23573 PCT Pub. Date Aug. 8, 1996An oxidation and/or combustion catalyst comprising at least one metal or oxide thereof chosen from the group consisting of palladium, platinum, nickel, cobalt and iron which is in combination with zinc metal or zinc metal oxide so as to result in a catalyst having said metal or oxide thereof to zinc metal or zinc metal oxide in a molar ratio of 1:2 and the catalyst is in the form of a close admixture or alloy, the catalyst further comprising a rare earth metal oxide.
Patent NZ-309125-A (NZ)
Title: Improvements in or relating to contrast agents
Inventor: DUGSTAD HARALD
IPC: A61K49/22
Filed: 1996-06-07
Abstract: iagnostic contrast agents having microbubbles of gas or a gas precursor stabilised by one or more membrane-forming lipids crosslinked or polymerised amphiphilic material, preferably, a dialkanoylphosphatidylserine/choline polymerised in the hydrophilic portion.  The agents may exhibit high degrees of stability and contrast efficacy.
Patent NZ-331766-A (NZ)
Title: Fungicide mixtures comprising an oxime ether, a carbamate and a morpholine or pyridine derivative
Inventor: MULLER RUTH
IPC: A01N37/52
Filed: 1997-04-22
Abstract: The fungicide mixtures contain in a synergistically effective amount (a) an oxime ether of the formula (I) in which the substituents have the following meaning: X is oxygen or amino (NH); Y is CH or N; Z is oxygen, sulphur, amino (NH) or C1-C4-alkylamino (N-C1-C4-alkyl); R' is C1-C6-alkyl, C1-C6-haloalkyl, C3-C6-alkenyl, C2-C6-haloalkenyl, C3-C6-alkynyl, C3-C6-haloalkynyl, C3-C6-cycloalkyl-methyl or benzyl, which can be either partially or completely halogenized and/or can carry one to three of the following radicals: cyano, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, and C1-C4-alkylthio, and/or (b) a carbamate of the formula (II) in which T means CH or N, n is 0, 1, or 2 and R means halogen, C1-C4-alkyl, or C1-C4-haloalkyl, where the radicals can be different, if n is 2, and (c) a morpholine or piperidine derivative (III) selected from the group of compounds (IIIa), (IIIb), (IIIc) in which n is 10, 11, 12 or 13.
Patent NZ-335163-A (NZ)
Title: Telecommunications network with portability of mobile subscriber number
Inventor: KALLIONIEMI KARL-ERIK
IPC: H04Q3/76
Filed: 1997-10-17
Abstract: A telecommunications network (10) comprises a set of service provider/operator domains (20), including mobile telecommunications domains (20A-20C).  A call-originating domain (20F) accesses a mobile subscriber number portability database (30F) to obtain the address of the gateway node (GMSC) of the telecommunications domain which currently serves a called mobile subscriber having a mobile station (70), and optionally the address of the home location register (HLR) of the called mobile subscriber.  The address of the gateway node obtained from the database (and optionally the address of the home location register) are included along with the directory number (MSISDN) or IMSI of the called mobile subscriber in a routing message for completing the call.  When changing service providers (e.g., changing to a new domain), the mobile subscriber number portability database is updated to reflect the change.  Access of the database and usage of the address of the gateway node of the new domain in the routing message permit the mobile subscriber to retain the same MSISDN when changing service providers.
Patent NZ-500791-A (NZ)
Title: Gene transfer with adenoviruses having modified fiber proteins
Inventor: MCCLELLAND ALAN
IPC: C12N5/10
Filed: 1998-04-30
Abstract: A method of transferring at least one DNA sequence into cells by transducing the cells, in vivo or ex vivo, with a modified adenovirus. The adenovirus, prior to modification, is of a first serotype. In the modified adenovirus, at least a portion of the fibre, and in particular the head portion, is removed from the adenovirus of the first serotype and replaced with a portion, in particular the head portion, of the fibre of an adenovirus of a second serotype. Such method is useful in transducing cells which may be refractory to the adenovirus of the first serotype, yet include a receptor which binds to the head portion of the fibre of the adenovirus of the second serotype.
Patent NZ-501709-A (NZ)
Title: Pharmaceutical compositions comprising a compound having affinity for FKB12, a neurotrophic factor and a pharmaceuticl carrier
Inventor: ARMISTEAD DAVID M
IPC: A61K31/21
Filed: 1996-06-06
Abstract: The application relates to methods and pharmaceutical compositions for stimulating the growth of neurites in nerve cells. The compositions comprise a neurotrophic amount of a compound of the formula below, where A is O, NH or Nalkyl; T is heteroaryl, aryl or substituted cyclohexyl, E is O, CH-U. J is H or alkyl, K is alkyl, benzyl or cyclohexylmethyl, or J and K together form a 7 membered heterocyclic ring and B, D and U are as defined in the specification. which binds to the FK-506 binding protein (FKBP) and a neurotrophic factor, such as nerve growth factor NGF. The methods comprise treating nerve cells with the above-described compositions or compositions comprising the FKBP binding compound without a neurotrophic factor. The methods can be used to promote repair of neuronal damage caused by disease or physical trauma.
Patent NZ-511378-A (NZ)
Title: Process for the manufacture of 1-pentene or an alpha-olefin lower than 1-pentene in a pure form
Inventor: BECKER HANS
IPC: C07C41/06
Filed: 2001-04-27
Abstract: A process for the recovery as a feedstock of an alpha-olefin from a mixture containing mainly hydrocarbon compounds is described.  The hydrocarbon compounds, such as is obtained by Fischer-Tropsch synthesis after a crude separation of compounds boiling higher and/or lower than the alpha-olefin, wherein tertiary olefins of the mixture after superstoichiometrical addition of a low alcohol, are subjected to catalytic etherification and a stream derived by etherification fed jointly with the alpha-olefin.  The ethers produced and other high boiling reaction products are then subjected to a distillative separation of the compounds boiling higher than the olefin.
Patent NZ-511415-A (NZ)
Title: Multi-loci genomic analysis by a method of improved cycle sequencing
Inventor: VINAYAGAMOORTHY THURAIAYAH
IPC: C12Q1/6869
Filed: 1999-10-01
Abstract: A method of sequencing a nucleic acid in a reaction mixture comprising first and second nucleic acid target sequences. The target sequences may be present on the same or different nucleic acid molecules. First and second labelled sequencing primers are provided that are hybridizable, respectively, to the first and second nucleic acid target sequences. The second sequencing primer being at least as long as the total length of the first sequencing primer plus the length of the first target sequence. Each of the sequencing primer extension products beginning with the second sequencing primer will be longer than the primer extension products in the pool beginning with the first sequencing primer. Once the sequencing reactions have been completed, the lengths of the primer extension products in the pool may be detected by known methods, such as by gel electrophoresis